Forbes December 2, 2025
William A. Haseltine

Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike to confront a pivotal question: should we repair a faulty gene or silence it altogether? This is the foundation for innovations that could one day eradicate inherited diseases, transform cancer treatment and even reshape how we think about aging itself. As highlighted in Destiny’s Child No Longer, these advances are not the stuff of distant science fiction. They are unfolding now. They represent a true fork in the road for the future of medicine and the destinies of millions of patients.​

The decision to alter a gene or knock it out has become the linchpin of modern gene therapy, relying on sophisticated technology...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech, Provider
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article